Direct Digital Holdings (DRCT) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
29 Apr, 2026Company overview and business model
Operates a full-service advertising and marketing platform, offering ad tech, data-driven campaign optimization, and solutions for brands, agencies, and middle market businesses across both sell- and buy-side digital advertising.
Formed through acquisitions of Colossus Media (sell-side SSP), Huddled Masses, and Orange 142 (buy-side DSP), with a unified buy-side business as of October 2024.
Focuses on programmatic advertising, targeting small and mid-sized businesses transitioning to digital, and provides inventory across web, mobile, and connected TV.
Financial performance and metrics
Reported net loss attributable to the company of $(18.9) million for 2025 and $(6.2) million for 2024.
Stockholders' deficit of $(7.0) million as of December 31, 2025.
Weighted average common shares outstanding (post-reverse split): 77,000 in 2025 and 17,000 in 2024.
Use of proceeds and capital allocation
May receive up to $50 million in gross proceeds from sales of Class A Common Stock to Roth Principal Investments under the Purchase Agreement.
Net proceeds intended to reduce outstanding debt (if required by debt agreements) and for general corporate purposes, including working capital.
Latest events from Direct Digital Holdings
- Gross margin rose to 34% and adjusted EBITDA loss narrowed, despite an 18% revenue decline.DRCT
Q1 202611 May 2026 - Buy-side revenue surged 28% in Q4 as strategic shifts and capital actions target 2026 recovery.DRCT
Q4 202511 May 2026 - Executing a turnaround with direct DSP integrations after a 2024 revenue dip.DRCT
Investor presentation10 Feb 2026 - Shelf registration allows up to $400M in securities to fund growth amid ongoing industry risks.DRCT
Registration Filing10 Feb 2026 - Digital ad platform seeks up to $100M via equity facility amid liquidity and operational risks.DRCT
Registration Filing4 Feb 2026 - Q3 revenue plunged 85% year-over-year, with recovery and liquidity actions underway.DRCT
Q3 202414 Jan 2026 - Revenue dropped 60% in 2024, but margin gains and new initiatives support a 2025 rebound.DRCT
Q4 202426 Dec 2025 - Shareholders to vote on reverse split, major share issuances, and incentive plan expansion.DRCT
Proxy Filing18 Dec 2025 - Shareholders to vote on reverse split, major share issuances, and incentive plan expansion.DRCT
Proxy Filing15 Dec 2025